• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

SAGE Open Med . Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to

tetano

Editor, Senior Moderator
SAGE Open Med


. 2024 Aug 28:12:20503121241272518.
doi: 10.1177/20503121241272518. eCollection 2024. Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19

Kosuke Matsuzono[SUP] 1 [/SUP], Makiko Mieno[SUP] 2 [/SUP], Takafumi Mashiko[SUP] 1 [/SUP], Yuhei Anan[SUP] 1 [/SUP], Tadashi Ozawa[SUP] 1 [/SUP], Reiji Koide[SUP] 1 [/SUP], Ryota Tanaka[SUP] 1 [/SUP], Akio Kimura[SUP] 3 [/SUP], Shigeru Fujimoto[SUP] 1 [/SUP]



Affiliations
Abstract

Objective: We investigated the effect of the pandemic on neurological hospitalizations and complications associated with severe acute respiratory syndrome coronavirus 2 infection or vaccinations.
Methods: We retrospectively analyzed data of patients hospitalized in our neurology division from 1 April 2019 to 31 March 2022 as the opt-out study. We classified the neurological diseases into nine subgroups, evaluated changes of neurological disease characteristics, and analyzed patients hospitalized with the complications from severe acute respiratory syndrome coronavirus 2 infection or after the coronavirus disease 2019 vaccination over three eras based on the pandemic stages: (1) pre-pandemic, (2) during the pandemic but before vaccines, and (3) during the pandemic with vaccines.
Results: Overall, 1756 patients were included in the analyses. The patient characteristics significantly changed throughout the pandemic (p < 0.01). Although the number of autoimmune cases did not change throughout the pandemic (p = 0.53), that of psychological cases and that of unknown cases were significantly changed (p < 0.05, p < 0.01). There were four infectious cases and 11 cases following vaccination from 1 April 2020 to 31 March 2022. The 11 postvaccination cases involved 10 kinds of neurological diseases.
Conclusions: The neurological characteristics significantly changed throughout the pandemic and there were diverse neurological complications following vaccinations.

Keywords: Autoimmunity; COVID-19; COVID-19 vaccines; neurologic manifestations; stroke.

 
Back
Top Bottom